Nano-X Imaging (NASDAQ:NNOX - Get Free Report) will be issuing its quarterly earnings data before the market opens on Thursday, November 21st. Investors that are interested in registering for the company's conference call can do so using this link.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last posted its quarterly earnings results on Tuesday, August 20th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by ($0.01). The company had revenue of $2.70 million during the quarter. Nano-X Imaging had a negative net margin of 567.41% and a negative return on equity of 30.34%. During the same period in the previous year, the business earned ($0.31) EPS. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Nano-X Imaging Trading Down 3.1 %
NASDAQ NNOX traded down $0.19 on Thursday, reaching $6.03. 1,168,877 shares of the company were exchanged, compared to its average volume of 1,788,119. The business's fifty day moving average price is $6.07 and its 200 day moving average price is $7.28. The stock has a market capitalization of $348.41 million, a P/E ratio of -6.29 and a beta of 2.01. Nano-X Imaging has a fifty-two week low of $5.26 and a fifty-two week high of $14.28.
Analyst Ratings Changes
Separately, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $14.00 target price on shares of Nano-X Imaging in a research note on Monday, September 23rd.
View Our Latest Research Report on Nano-X Imaging
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
See Also
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.